Open AccessTrends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting
Author(s) -
Niels Hoedemaker,
Peter Damman,
Jan Paul Ottervanger,
J. H. E. Dambrink,
A.T. Marcel Gosselink,
Elvin Kedhi,
Evelien Kolkman,
Robbert J. de Winter,
Arnoud W.J. van ‘t Hof
Publication year - 2018
Publication title -
european heart journal - cardiovascular pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.895
H-Index - 26
eISSN - 2055-6845
pISSN - 2055-6837
DOI - 10.1093/ehjcvp/pvy005
Subject(s) - acute coronary syndrome , medical prescription , medicine , emergency medicine , medical therapy , intensive care medicine , cardiology , myocardial infarction , pharmacology
Optimal medical therapy (OMT) is recommended in acute coronary syndrome (ACS) patients. Few studies present temporal trends of OMT prescription and its impact on outcomes in a real-world setting. We aimed to evaluate OMT prescription in a real-world ACS population and its relation to mortality during almost a decade.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom